Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Biotechnology company completes $3.37 million financing
June 6th, 2005
Senesco Technologies, Inc. (SNT) closed on its previously announced private placement to institutional and accredited investors, consisting of 1,595,651 shares of common stock and warrants to purchase 797,836 shares of common stock. Aggregate gross proceeds to the company were approximately $3.37 million. In connection with the private placement, Senesco has agreed to file a registration statement on form S-3 to register the shares of common stock and the shares underlying the warrants. Oppenheimer & Co. acted as the placement agent for this transaction. Senesco takes its name from the scientific term for the aging of plant cells:...
Source: Biotech Business Week (2005-06-06)
|
